Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Transplantation in Hidradenitis Suppurativa
NCT07668713Phase 1Not yet recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2026
- Primary completion
- Jun 2030
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of allogeneic fecal microbiota in hidradenitis suppurativa (HS), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: International Hidradenitis Suppurativa Severity Score System at 12 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT07668713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668713.